IGF2BP2 and esophageal squamous cell carcinoma: Subsequently, after treatment with actinomycin D, the mRNA stability of GPX4 decreased at the planned time point, indicating that TMEM44-AS1 may interact with IGF2BP2 in ESCC to promote the stability of GPX4 mRNA (Fig. 5L).